In November 2023, experts from the evaluation team of Fangyuan Logo Certification Group conducted an annual supervision and evaluation of the operation of the quality management system of GB/T 19001-2016/ISO 9001:2015 for Leadingpharm and its subsidiary Zhengzhou Deep Blue Ocean. They also conducted the first quality system review for the Leadingpharm (Chongqing) Pharmaceutical subsidiary.
 

Since the first ISO9001 certification was passed by Leadingpharm in 2019, the overall level of the internal audit team of the company has been significantly improved under the long-term and strict accompanying audit and guidance of the evaluation team led by Professor Yang. Through immersive training of new employees for 1-3 years, we have truly achieved the quality policy of "practicing pharmaceutical clinical quality control throughout the entire process, and jointly creating a leading R&D service quality in the entire industry chain". The supervision and review achieved satisfactory results, and the experts in the review team highly recognized and praised Leadingpharm's understanding and independent implementation of the quality management system. Leadingpharm (Chongqing) Pharmaceutical has also successfully obtained the sub certificate of quality system recognition.
 

Quality and efficiency are the lifeline of sustainable development for enterprises, as well as the core competitiveness of CXO enterprises. Leadingpharm attaches great importance to quality management, with the leadership of the company's President's Office and Board of Directors, The heads of each department serve as the first person in charge, and all staff participate in the implementation of management. They continuously strengthen risk control awareness, strengthen training on standard management system content, strictly implement internal management audits, and continuously discover problems and improve during operation. Strive to create maximum value for customers and provide higher quality services.
 

During the preparation process for this audit, each department carefully reviewed the operation of the quality management system, and strengthened supervision and inspection work in accordance with the requirements of ISO 9001:2015 quality management system. During the audit process, in-depth communication and discussion with the audit team experts are carried out to truly deepen learning during inspection and audit, and to promote high-quality management through a sound system.
 

Ms. Julie Gao, president of Leadingpharm, delivered a speech at the final meeting. She first expressed sincere gratitude to the audit team experts for their continuous guidance on the quality management system, as well as to all the members of Leadingpharm for their serious and responsible work. She stated that Leadingpharm has always adhered to the foundation of continuous innovation in the technology platform, and through continuous iteration and upgrading of the quality management system, can create greater value for customers in the new uncertain pharmaceutical era. The company will also leverage its quality management system to carry out certification and annual audits, ensuring the efficient and high-quality achievement of its strategic goals, and enhancing the organization's ability for continuous innovation and improvement.
 

Finally, thank you to all the executives for their joint efforts. We look forward to the continuous improvement of all members of Leadingpharm and the leapfrog improvement of the company's quality management system in 2024!